Chronic THC administration suppressed intestinal inflammation, preserved gut barrier proteins, and prevented lymph node fibrosis in SIV-infected rhesus macaques.
HIV/AIDS researchers, gastroenterologists, immunologists, and people living with HIV interested in cannabis research.
0/8 THC-treated had fibrosis vs. 9/9 controls
What the researchers found
THC-treated SIV-infected macaques showed downregulated pro-inflammatory microRNAs and genes, higher expression of tight junction proteins (occludin, claudin-3), reduced T cell activation, increased anti-inflammatory macrophages, and complete prevention of lymph node fibrosis seen in all vehicle-treated animals.
Why it matters
HIV-associated gut inflammation drives disease progression and is difficult to treat even with antiretroviral therapy. THC's ability to reduce intestinal inflammation and prevent the irreversible lymph node fibrosis that characterizes chronic HIV infection represents a potentially significant therapeutic avenue.
The numbers in context
THC prevented lymph node fibrosis in all 8 treated animals (0/8 fibrosis) vs. all 9 vehicle-treated animals showing fibrosis (9/9). MMP8 (tissue-degrading enzyme) was significantly downregulated via miR-204 targeting.
How the study worked
Chronically SIV-infected rhesus macaques received either THC (n=8) or vehicle (n=9). Researchers profiled miRNA and mRNA expression in colon tissue, assessed gut barrier proteins, measured T cell activation by flow cytometry, and examined lymph node fibrosis.
What this study cannot tell us
Primate model, not human clinical data. Sample sizes were small (8-9 per group). Long-term effects of chronic THC use in immunocompromised individuals need human study. THC dosing may not match typical human use patterns.
How to read the evidence
Moderate: well-designed primate study with detailed molecular mechanisms, though no human data.
When this study was published
Published in 2019.
The bigger picture
This is among the most detailed mechanistic studies of THC's anti-inflammatory effects in a primate model of HIV. The finding that THC prevented lymph node fibrosis, an irreversible consequence of chronic inflammation, is particularly striking.
Questions still open
- Do these gut-protective effects translate to people living with HIV? Could THC or targeted cannabinoid therapy prevent or reverse lymph node fibrosis in humans?
Common questions
How did THC protect the gut in this study?
What is lymph node fibrosis and why does it matter?
Read the original research
Cannabinoid Attenuation of Intestinal Inflammation in Chronic SIV-Infected Rhesus Macaques Involves T Cell Modulation and Differential Expression of Micro-RNAs and Pro-inflammatory Genes.
Frontiers in immunology, 10, 914
Citation
Kumar, Vinay; Torben, Workineh; Mansfield, Joshua; Alvarez, Xavier; Vande Stouwe, Curtis; Li, Jian; Byrareddy, Siddappa N; Didier, Peter J; Pahar, Bapi; Molina, Patricia E; Mohan, Mahesh. (2019). Cannabinoid Attenuation of Intestinal Inflammation in Chronic SIV-Infected Rhesus Macaques Involves T Cell Modulation and Differential Expression of Micro-RNAs and Pro-inflammatory Genes.. Frontiers in immunology, 10, 914. https://doi.org/10.3389/fimmu.2019.00914
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk